Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05728866 · ClinicalTrials.gov registry record · NA

Effectiveness of IVR Combined With Task-Specific Training on Hemiplegic Arm Function Following Stroke

A NA study, sponsored by Virginia Commonwealth University.

Completed
Registry status
NA
Development phase
13
Enrollment target

NCT05728866: Completed NA study, sponsored by Virginia Commonwealth University.

NCT05728866 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05728866, a NA study, has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
NA
Development phase
13 participants
Enrollment target

Study Summary

The purpose of this research study is to understand the efficacy of using an immersive Virtual Reality (VR) environment, with task-specific training, to encourage arm movement following stroke.

Primary Outcome

Arm movements will be measured using wrist-worn accelerometers. Amount of movement will be measured prior to and following the intervention

Interventions

  • PROCEDURE VR immersive therapy

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2023-03-12
Est. Completion 2025-11-20
Phase NA
Virginia Commonwealth University

558 total trials

What the finished NCT05728866 record still lists

NCT05728866 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which VR immersive therapy is the first listed.

NCT05728866 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05728866 about?

NCT05728866 is a clinical study titled "Effectiveness of IVR Combined With Task-Specific Training on Hemiplegic Arm Function Following Stroke". The purpose of this research study is to understand the efficacy of using an immersive Virtual Reality (VR) environment, with task-specific training, to encourage arm movement following stroke.

What is the current status of trial NCT05728866?

This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2023-03-12. Estimated completion is 2025-11-20.

What interventions are being tested in trial NCT05728866?

The interventions under investigation include: VR immersive therapy (PROCEDURE).

Who is sponsoring clinical trial NCT05728866?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05728866's enrollment target sits among peer trials

13 1911th of 2000 higher than 88 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03125655 · 13 participants

    Regulation of Inflammatory Genes in Psoriasis

  • NCT03774446 · 13 participants · Phase 2

    Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

  • NCT03830151 · 13 participants · Phase 1

    Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

  • NCT04573231 · 13 participants · Phase 2

    Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05728866, the US trial registry maintained by the National Library of Medicine. NCT05728866 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.